Social Anxiety Disorder Study Of Paroxetine

2014-07-23 21:45:12 | BioPortfolio


This study is designed to evaluate the efficacy and safety in Social Anxiety Disorder (SAD).

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Phobic Disorders


Paroxetine hydrochloride hydrate





Results (where available)

View Results


Published on BioPortfolio: 2014-07-23T21:45:12-0400

Clinical Trials [927 Associated Clinical Trials listed on BioPortfolio]

Long-Term Study Of Paroxetine in Women and Men

This study is designed to evaluate the efficacy and safety in Social Anxiety Disorder (SAD)

Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)

This is a single-blind, placebo-controlled, parallel group study to evaluate the efficacy of BRL29060A (paroxetine hydrochloride hydrate, hereafter paroxetine) administered orally over the...

RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo

We aim to (1) evaluate the effectiveness of cognitive therapy and paroxetine and their combination, (2) investigate the patterns of change and the mechanisms of action involved during trea...

Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg

The objective of this study is to investigate the bioequivalence of Mylan's paroxetine hydrochloride 40 mg tablets to GSK's Paxil® 40 mg tablets following a single, oral 40 mg (1 x 40 mg)...

Secondary Prevention With Paroxetine vs. Placebo in Subthreshold PTSD

The purpose of this study is: 1) To document the effectiveness and tolerability of paroxetine for the treatment of subthreshold PTSD in veterans in the early post-deployment period; and 2)...

PubMed Articles [5942 Associated PubMed Articles listed on BioPortfolio]

Implicit attitudes toward dieting and thinness distinguish fat-phobic and non-fat-phobic anorexia nervosa from avoidant/restrictive food intake disorder in adolescents.

The majority of individuals with anorexia nervosa (AN) have a fat-phobic (FP-AN) presentation in which they explicitly endorse fear of weight gain, but a minority present as non-fat-phobic (NFP-AN). D...

Hydrazine hydrate and organosolv synergetic pretreatment of corn stover to enhance enzymatic saccharification and co-production of high-quality antioxidant lignin.

Hydrazine hydrate and organosolv synergetic pretreatment of corn stover was developed. With the aid of alkaline and reductive hydrazine hydrate, a high delignification rate (77.94%) and total sugar yi...

CH4 nanobubbles on the hydrophobic solid-water interface serving as the nucleation sites of methane hydrate.

The surface hydrophobicity of solid particles play a critical role in the nucleation of gas hydrate formation and found that the hydrophobic surface will promote this nucleation process but the underl...

Cortical alterations in phobic postural vertigo - a multimodal imaging approach.

Functional dizziness syndromes are among the most common diagnoses made in patients with chronic dizziness, but their underlying neural characteristics are largely unknown. The aim of this neuroimagin...

Phase Diagram of Methane Hydrates and Discovery of MH-VI Hydrate.

Methane hydrate is not only the predominantly natural deposits of permafrost and continental margins of Earth but also the dominant methane-containing phase in the nebula and major moons of gas giants...

Medical and Biotech [MESH] Definitions


Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.

A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311)

An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

A serotonin uptake inhibitor that is effective in the treatment of depression.

More From BioPortfolio on "Social Anxiety Disorder Study Of Paroxetine"

Quick Search


Relevant Topics

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Searches Linking to this Trial